Sitagliptin-Mepha 25 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-mepha 25 mg compresse rivestite con film

mepha pharma ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini malas, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 0.26 mg. - farmaco antidiabetico orale - synthetika

Sitagliptin-Mepha 50 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-mepha 50 mg compresse rivestite con film

mepha pharma ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini malas, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.52 mg. - farmaco antidiabetico orale - synthetika

Sitagliptin-Mepha 100 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-mepha 100 mg compresse rivestite con film

mepha pharma ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini malas, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.04 mg. - farmaco antidiabetico orale - synthetika

Sitagliptin Metformin Spirig HC 50/500 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin metformin spirig hc 50/500 mg compresse rivestite con film

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 500 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.03 mg. - il diabete mellito di tipo 2 - synthetika

Sitagliptin Metformin Spirig HC 50/850 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin metformin spirig hc 50/850 mg compresse rivestite con film

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 850 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. - il diabete mellito di tipo 2 - synthetika

Sitagliptin Metformin Spirig HC 50/1000 mg Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin metformin spirig hc 50/1000 mg compresse rivestite con film

spirig healthcare ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.02 mg. - il diabete mellito di tipo 2 - synthetika

Segluromet الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.